# ME Instruments

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/me-instruments

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.me-itech.com
- Latest round: Series C (Jun 13, 2025)
- Investors on record: 1

## About

Based in Shenzhen, China, and founded in 2018, ME Instruments Inc. operates as a gene sequencing technology and application vendor, dedicated to the innovative development and application of sequencing reagents, sequencing technologies, and sequencing platforms. The co-founder, Jingyue Ju, is the Director of the Centre for Gene Technology at Columbia University. The company has set up branch offices in Beijing and Chongqing. It has acquired 3 utility model patents and one invention patent. In June 2025, ME Instruments Inc. closed series C+ funding from new investor Zhonghuijin Group. ME Instruments Inc. specialises in gene sequencers and ancillary equipment, sequencing reagents, enzyme reagents, and software development. Its main product, the UniSeq2000 sequencer, is a desktop, clinical application NGS sequencer. The sequencer adopts microfluidic chip technology and monochromatic fluorescence luminescence sequencing chemistry and can sequence genes from different kinds of scientific research and clinical samples. The company also offers universal kits for sequencing reactions and molecular tool enzymes. The products and technologies can be used in the detection of clinical pathogens, genetic screening, cancer diagnosis, and the diagnosis and treatment of cardiovascular diseases. The company’s revenue is generated by providing gene sequencing analysis platform and related technologies. The company plans to build a scale gene sequencing platform production base in Lianyungang.

## Funding rounds

- Series C, Jun 13, 2025 — Zhonghuijin Group

## Investors

- Zhonghuijin Group — Series C